Cipla Gets Tentative FDA OK For Tenofovir Disoproxil Fumarate
05 5월 2009 - 8:17PM
Dow Jones News
Cipla Ltd. (500087.BY) said Tuesday it has secured tentative
approval from the U.S. Food and Drug Administration for tenofovir
disoproxil fumarate, used to treat HIV.
It has received tentative approval to sell the drug in tablet
form in dosages of 300 milligram under the President's Emergency
Plan for AIDS Relief program, the Indian drugmaker said in a note
to the Bombay Stock Exchange.
Tenofovir disoproxil fumarate tablets are the generic version of
Gilead Sciences Inc.'s (GILD) truvada.
-By Satish Sarangarajan; Dow Jones Newswires; +91 22 6145 6120;
satish.sarangarajan@dowjones.com